恩替卡韦联合调控免疫方治疗e抗原阳性慢性乙型肝炎患者时免疫功能分(2)
第1页 |
参见附件。
参考文献
[1] 乔燕伟,游晶。慢性乙型病毒性肝炎患者T细胞亚群研究进展。临床肝胆病杂志,2005,25:383-385
[2] 贾继东,李兰娟.慢性乙型肝炎防治指南(2010年版) [J] .肝脏,2011(01):7-21.
[3] 陈大明.乙肝防治的情报学研究[D].中国科学院研究生院(上海生命科学研究院),2007.
[4] 金伯泉,李恩善,徐辉等。细胞和分析免疫学[M]。北京:世界图书出版社,1995:259-285
[5] Schlaak JF,Tully G,Lohy HF,et al.HBV-specific immune defection chromic hepatitsiB(CHB) is correlated with dysregulation of pro-and anti-inflammatory cytokines[J].Clin Exp Immunol.1999,115(3):508-514.
[6] LiuF.Li MH.Lu Y. et al. The cytotoxic effect of CD8+ T subsets plays an important role in the chronic hepatitis B [J]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi.2011.25(1):29-32.
[7] Nascimbeni M. Pol S. Saunier B. et al. Distinct CD4+ and CD8+ double-positive T cell in the blood and liver of patients during chronic hepatitis B and C [J]. PLoS One .2011.6(5):e20145.
[8] Sun XH Liu QL. Li M .et al. The study of CD4+ and CD8+ T subsets in chronic hepatitis B patients [J]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi.2011.27(5):545-547.550.
[9] Shi F.Zhang JY . Zeng Z .et al. Skewed ratios between CD3+ T cells and monocytes are associated with poor prognosis in patierts with HBV-related acute-on-chronic liver failure [J]. Biochem Biophys Res Commun. 2010.402(1):30-36.
您现在查看是摘要介绍页,详见PDF附件。